Editorial: Gastrointestinal Tumor Heterogeneity and Related Anti-Cancer Strategies

Rui Liao; Yu-Jun Shi; Michael D Chuong; Ju Cao

doi:10.3389/fonc.2022.873240

Editorial: Gastrointestinal Tumor Heterogeneity and Related Anti-Cancer Strategies

Front Oncol. 2022 Apr 11:12:873240. doi: 10.3389/fonc.2022.873240. eCollection 2022.

Authors

Rui Liao¹, Yu-Jun Shi², Michael D Chuong^{3

4}, Ju Cao⁵

Affiliations

¹ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
² Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, National Health Commission (NHC), West China Hospital, Sichuan University, Chengdu, China.
³ Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, United States.
⁴ Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
⁵ Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

No abstract available

Keywords: gastrointestinal tumor; inter-patient heterogeneity; intra-tumor heterogeneity; phenotypic plasticity; targeted therapy; tumor microenvironment.

Publication types

Editorial